insights_auto
Why is CUV up 2.29%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.59
arrow_upward
+2.29%(+0.17) 1D
Nov 16, 4:10:15 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.43
High
A$7.65
Low
A$7.38
Mkt. cap
383.20M
Avg. vol.
157.65K
Volume
90.51K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.36
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.43
High
A$7.65
Low
A$7.38
Mkt. cap
383.20M
Avg. vol.
157.65K
Volume
90.51K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.36
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
Business Insider
·
43 minutes ago
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Reuters
·
14 minutes ago
S&P 500, Nasdaq futures slide as Nvidia earnings, Anthropic debut loom
Benzinga
·
1 hour ago
Stock Market Today: Dow Jones, S&P 500 Futures Trade Mixed as Scott Bessent Presses Nvidia Over China Chi
Billionaires.Africa
·
1 hour ago
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com